These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 31097715)
1. Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells. Ndreshkjana B; Çapci A; Klein V; Chanvorachote P; Muenzner JK; Huebner K; Steinmann S; Erlenbach-Wuensch K; Geppert CI; Agaimy A; Ballout F; El-Baba C; Gali-Muhtasib H; Roehe AV; Hartmann A; Tsogoeva SB; Schneider-Stock R Cell Death Dis; 2019 May; 10(6):379. PubMed ID: 31097715 [TBL] [Abstract][Full Text] [Related]
2. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Cho YH; Ro EJ; Yoon JS; Mizutani T; Kang DW; Park JC; Il Kim T; Clevers H; Choi KY Nat Commun; 2020 Oct; 11(1):5321. PubMed ID: 33087710 [TBL] [Abstract][Full Text] [Related]
3. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
4. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype. Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530 [TBL] [Abstract][Full Text] [Related]
5. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. Prabhu VV; Allen JE; Dicker DT; El-Deiry WS Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124 [TBL] [Abstract][Full Text] [Related]
6. Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells. An J; Ha EM J Microbiol Biotechnol; 2016 Aug; 26(8):1490-503. PubMed ID: 27221111 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling. Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919 [TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional Monzer A; Wakimian K; Ballout F; Al Bitar S; Yehya A; Kanso M; Saheb N; Tawil A; Doughan S; Hussein M; Mukherji D; Faraj W; Gali-Muhtasib H; Abou-Kheir W World J Gastroenterol; 2022 Sep; 28(33):4787-4811. PubMed ID: 36156922 [TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor. Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357 [TBL] [Abstract][Full Text] [Related]
13. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation. Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235 [TBL] [Abstract][Full Text] [Related]
14. JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway. Kim MS; Cho HI; Yoon HJ; Ahn YH; Park EJ; Jin YH; Jang YK Sci Rep; 2018 Apr; 8(1):6611. PubMed ID: 29700375 [TBL] [Abstract][Full Text] [Related]
15. Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats. Kensara OA; El-Shemi AG; Mohamed AM; Refaat B; Idris S; Ahmad J Drug Des Devel Ther; 2016; 10():2239-53. PubMed ID: 27468227 [TBL] [Abstract][Full Text] [Related]
16. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance. Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840 [TBL] [Abstract][Full Text] [Related]
17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
18. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors. Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882 [TBL] [Abstract][Full Text] [Related]
19. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells. Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer. Huynh N; Shulkes A; Baldwin G; He H Cancer Biol Ther; 2016 Aug; 17(8):813-23. PubMed ID: 27260988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]